347 related articles for article (PubMed ID: 21939497)
1. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.
Patil S; Anitescu M
Pain Med; 2012 Feb; 13(2):263-9. PubMed ID: 21939497
[TBL] [Abstract][Full Text] [Related]
2. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
Correll GE; Maleki J; Gracely EJ; Muir JJ; Harbut RE
Pain Med; 2004 Sep; 5(3):263-75. PubMed ID: 15367304
[TBL] [Abstract][Full Text] [Related]
3. Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements.
Kapural L; Kapural M; Bensitel T; Sessler DI
Pain Physician; 2010; 13(4):389-94. PubMed ID: 20648208
[TBL] [Abstract][Full Text] [Related]
4. The use of sub-anesthetic intravenous ketamine and adjuvant dexmedetomidine when treating acute pain from CRPS.
Nama S; Meenan DR; Fritz WT
Pain Physician; 2010; 13(4):365-8. PubMed ID: 20648205
[TBL] [Abstract][Full Text] [Related]
5. Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study.
Sheehy KA; Muller EA; Lippold C; Nouraie M; Finkel JC; Quezado ZM
BMC Pediatr; 2015 Dec; 15():198. PubMed ID: 26620833
[TBL] [Abstract][Full Text] [Related]
6. Repeated and escalating preoperative subanesthetic doses of ketamine for postoperative pain control in patients undergoing tumor resection: a randomized, placebo-controlled, double-blind trial.
Rakhman E; Shmain D; White I; Ekstein MP; Kollender Y; Chazan S; Dadia S; Bickels J; Amar E; Weinbroum AA
Clin Ther; 2011 Jul; 33(7):863-73. PubMed ID: 21722959
[TBL] [Abstract][Full Text] [Related]
7. A pilot open-label study of the efficacy of subanesthetic isomeric S(+)-ketamine in refractory CRPS patients.
Kiefer RT; Rohr P; Ploppa A; Nohé B; Dieterich HJ; Grothusen J; Altemeyer KH; Unertl K; Schwartzman RJ
Pain Med; 2008; 9(1):44-54. PubMed ID: 18254766
[TBL] [Abstract][Full Text] [Related]
8. The use of ketamine in severe cases of refractory pain syndromes in the palliative care setting: a case series.
Kerr C; Holahan T; Milch R
J Palliat Med; 2011 Sep; 14(9):1074-7. PubMed ID: 21838517
[TBL] [Abstract][Full Text] [Related]
9. Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Orhurhu V; Orhurhu MS; Bhatia A; Cohen SP
Anesth Analg; 2019 Jul; 129(1):241-254. PubMed ID: 31082965
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study.
Kiefer RT; Rohr P; Ploppa A; Dieterich HJ; Grothusen J; Koffler S; Altemeyer KH; Unertl K; Schwartzman RJ
Pain Med; 2008 Nov; 9(8):1173-201. PubMed ID: 18266808
[TBL] [Abstract][Full Text] [Related]
11. The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury.
Kvarnström A; Karlsten R; Quiding H; Gordh T
Acta Anaesthesiol Scand; 2004 Apr; 48(4):498-506. PubMed ID: 15025615
[TBL] [Abstract][Full Text] [Related]
12. Complete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolam.
Kiefer RT; Rohr P; Ploppa A; Altemeyer KH; Schwartzman RJ
Pain Pract; 2007 Jun; 7(2):147-50. PubMed ID: 17559485
[TBL] [Abstract][Full Text] [Related]
13. [Ketamine infusion therapy for refractory neuralgia in spinal disease: report of two cases].
Matsuda W; Matsumura A; Enomoto T; Nose T; Suga A; Miyabe M; Toyooka H
No Shinkei Geka; 1999 Feb; 27(2):195-200. PubMed ID: 10065454
[TBL] [Abstract][Full Text] [Related]
14. The influence of timing of systemic ketamine administration on postoperative morphine consumption.
Bilgin H; Ozcan B; Bilgin T; Kerimoğlu B; Uçkunkaya N; Toker A; Alev T; Osma S
J Clin Anesth; 2005 Dec; 17(8):592-7. PubMed ID: 16427528
[TBL] [Abstract][Full Text] [Related]
15. An observational study on the effect of S+-ketamine on chronic pain versus experimental acute pain in Complex Regional Pain Syndrome type 1 patients.
Sigtermans M; Noppers I; Sarton E; Bauer M; Mooren R; Olofsen E; Dahan A
Eur J Pain; 2010 Mar; 14(3):302-7. PubMed ID: 19540140
[TBL] [Abstract][Full Text] [Related]
16. Successful use of ketamine infusion in the treatment of intractable cancer pain in an outpatient.
Chung WJ; Pharo GH
J Pain Symptom Manage; 2007 Jan; 33(1):2-5. PubMed ID: 17196899
[No Abstract] [Full Text] [Related]
17. The early and delayed analgesic effects of ketamine after total hip arthroplasty: a prospective, randomized, controlled, double-blind study.
Remérand F; Le Tendre C; Baud A; Couvret C; Pourrat X; Favard L; Laffon M; Fusciardi J
Anesth Analg; 2009 Dec; 109(6):1963-71. PubMed ID: 19923527
[TBL] [Abstract][Full Text] [Related]
18. Analgesic effect of intravenous ATP on postherpetic neuralgia in comparison with responses to intravenous ketamine and lidocaine.
Hayashida M; Fukuda K; Fukunaga A; Meno A; Sato K; Tarui K; Arita H; Kaneko Y; Hanaoka K
J Anesth; 2005; 19(1):31-5. PubMed ID: 15674513
[TBL] [Abstract][Full Text] [Related]
19. Subanaesthetic ketamine spares postoperative morphine and controls pain better than standard morphine does alone in orthopaedic-oncological patients.
Kollender Y; Bickels J; Stocki D; Maruoani N; Chazan S; Nirkin A; Meller I; Weinbroum AA
Eur J Cancer; 2008 May; 44(7):954-62. PubMed ID: 18396035
[TBL] [Abstract][Full Text] [Related]
20. Safety, tolerability, and short-term efficacy of intravenous lidocaine infusions for the treatment of chronic pain in adolescents and young adults: a preliminary report.
Mooney JJ; Pagel PS; Kundu A
Pain Med; 2014 May; 15(5):820-5. PubMed ID: 24423053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
